Adenocarcinoma Clinical Trials

A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Mobile Alabama 36688

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Alaska

UPDATED

Anchorage Alaska 99508

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Arizona

UPDATED

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Tucson Arizona

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Tucson Arizona 85710

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Tucson Arizona 85704

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Arkansas

UPDATED

Little Rock Arkansas 72205

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

California

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Atezolizumab [TECENTRIQ], Cobimetinib and Regorafenib for the treatment of Colorectal Cancer

UPDATED

Greenbrae California 94904

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

La Jolla California

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

La Jolla California 92093

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

La Jolla California 92037-0845

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

View More ▼

UPDATED

La Jolla California 92037-0845

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

La Jolla California 92093

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Los Angeles California

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Los Angeles California

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Los Angeles California 90048

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Mountain View California 94040

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Mountain View California 94040

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Palo Alto California 94301

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Pismo Beach California 93449

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Roseville California 95661

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Sacramento California 95816

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

San Diego California 92103

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

San Francisco California 94115

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

San Luis Obispo California 93401

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Santa Cruz California 95065

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Santa Rosa California 95403

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Sunnyvale California 94086

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Whittier California

A clinical research study for the treatment of Gastric Adenocarcinoma

Colorado

UPDATED

Aurora Colorado 80045

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Aurora Colorado 80045

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Aurora Colorado 80045

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Aurora Colorado 80012

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Aurora Colorado 80045

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

View More ▼

UPDATED

Colorado Springs Colorado 80909

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Denver Colorado

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Denver Colorado 80205

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Denver Colorado 80220

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Fort Collins Colorado 80524

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Lafayette Colorado 80026

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Littleton Colorado 80120

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Lone Tree Colorado 80124

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Lone Tree Colorado 80124

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Wheat Ridge Colorado 80033

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Connecticut

UPDATED

Fairfield Connecticut 06824

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

Hartford Connecticut 06102

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

UPDATED

New Britain Connecticut 06050

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer